- News
News
Scaling up to commercialise innovation in Scotland’s Bioeconomy
Today and tomorrow, on 15th and 16th March, biotechnologists will gather in Glasgow for this year’s Industrial Biotechnology Innovation Centre (IBioIC) Conference
More
- News
News
Biochemical synthesis discovery could unlock new drug development breakthroughs
A mystery about how a chemical compound found in nature could be synthesised in the lab may have been solved, scientists say – a breakthrough which could unlock new developments in medicine says University of Glasgow experts.
More
- News
News
Innovation passport awarded to Glasgow biopharma company
Aurum Biosciences has been recognised by the United Kingdom’s Innovative Licensing and Access Pathway (ILAP) and awarded an Innovation Passport for its state-of-the-art stroke technology.
More
- News
News
University of Glasgow spinout secures £8.75m for tennis elbow treatment trials
Causeway Therapeutics, a University of Glasgow spin-out specializing in tendon disease has raised £8.75M from investors to to advance development of microRNA therapeutics.
More
- News
News
UWS research suggests grass species offers cancer treatment potential
A drought-resistant perennial grass could help in the fight against cancer, University of the West of Scotland (UWS) research has revealed.
More
- News
News
Strathclyde launch online course to support medicine use for older people with sensory impairments
The course is aimed at people with a professional interest in the subject, notably health and social care professionals, as well as students, family carers and people considering a career in these professions.
More
- News
News
Strathclyde spin-out raises £10M to develop pioneering liquid biopsy platform for early-stage cancers
DxCover, A clinical-stage diagnostics firm founded out of research carried out at the University of Strathclyde has raised almost £10 million for its novel technology for early detection of multiple cancers.
More
- News
News
Strathclyde spin-out raises £10M to develop pioneering liquid biopsy platform for early-stage cancers
DxCover, A clinical-stage diagnostics firm founded out of research carried out at the University of Strathclyde has raised almost £10 million for its novel technology for early detection of multiple cancers.
More